Arcus Biosciences
- Market cap
- 3.12B
- P/E (TTM)i
- -6.22
- P/Bi
- 6.73
- EPSi
- -3.29
- Div yieldi
- 0.00%
- 52W posi
- 57%
Anonymous reader poll. Unscientific, not investment advice.
Arcus Biosciences shares were changing hands at 24.52, up 0.99% on the day. The company carries a market value of roughly 3.12B, the #2467 most valuable US-listed company we track. Valuation-wise, the P/E sits at -6.16, 525% below the five-year average of 1.45. The 9 analysts covering the stock are, on balance, at Buy, targeting an average of 42.13 (+72%). Against a 52-week band of 15.09-31.74, the shares are currently 57% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 days.
- Recent price momentum is +27.9% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 10.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 24.28
- Open
- 24.23
- Day range
- 23.90 - 24.85
- Avg price
- 24.53
- Volume
- 1.60M
- Turnover
- 39.27M
- Turnover ratei
- 1.77%
- Volume ratioi
- 1.34
- Amplitudei
- 3.91%
- 52-week rangei
- 15.09 - 31.74
Valuation
- P/Ei
- -7.45
- P/E (TTM)i
- -6.22
- P/Bi
- 6.73
- EPSi
- -3.29
- Book value / shi
- 3.64
- Net profit
- -418.93M
- Net assets
- 464.00M
Share structure
- Market cap
- 3.12B
- Float capi
- 2.22B
- Shares out
- 127.33M
- Float sharesi
- 90.53M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2018-03-15
22.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+10.66M net over the window
Short interest
- Shares short
- 13.81M
- % of floati
- 10.85%
- Days to coveri
- 7.81
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Arcus Biosciences (RCUS)?
Arcus Biosciences last traded at 24.52. The quote on this page refreshes every few seconds while US markets are open.
What is Arcus Biosciences's market cap?
About 3.12B.
What is the P/E ratio of Arcus Biosciences?
The trailing twelve-month P/E is -6.22, below its own 5-year average of 1.45 — toward the bottom of its historical range (23.68% percentile). See the Valuation tab for the full history.
Does Arcus Biosciences pay a dividend?
Arcus Biosciences does not currently pay a regular dividend.
Is Arcus Biosciences a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 42.13, which implies 71.8% upside from the current price. This is not investment advice.
What is Arcus Biosciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Arcus Biosciences a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.